Botulinumtoxin in der Schmerztherapie

T. Probst(Klinik und Poliklinik für Neurologie), E. Kunesch(University of Rostock), R. Benecke(Children's Hospital of Philadelphia), Dirk Dressler(Tongji University)

Aktuelle Neurologie

October 1, 2002

10.1055/s-2002-34965

Cited by 2

Related Papers

Transcranial magnetic stimulation of the human brain: responses in muscles supplied by cranial nerves

|Experimental Brain Research|1988|304

On the origin of the postexcitatory inhibition seen after transcranial magnetic brain stimulation in awake human subjects

|Experimental Brain Research|1993|303

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Compare the Efficacy and Safety of Three Doses of Botulinum Toxin Type A (Dysport) With Placebo in Upper Limb Spasticity After Stroke

|Stroke|2000|298

Reorganisation of descending motor pathways in patients after hemispherectomy and severe hemispheric lesions demonstrated by magnetic brain stimulation

|Experimental Brain Research|1991|292

Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency

|Journal of Neurology|1999|276